BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10133561)

  • 1. The financial impact of investigational drug services.
    Rogers SD; Lampasona V; Buchanan EC
    Top Hosp Pharm Manage; 1994 Apr; 14(1):60-6. PubMed ID: 10133561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fee structure for investigational drug studies.
    Anandan JV; Isopi MJ; Warren AJ
    Am J Hosp Pharm; 1993 Nov; 50(11):2339-43. PubMed ID: 8266958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and funding of a pharmacy-based investigational drug service.
    Ryan ML; Colvin CL; Tankanow RM
    Am J Hosp Pharm; 1987 May; 44(5):1069-74. PubMed ID: 3605116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a fee for handling investigational drug studies.
    Ngu BQ; Schneider PJ; Kilarski DJ
    Am J Hosp Pharm; 1982 Aug; 39(8):1308-10. PubMed ID: 7124750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National survey of pharmacy-coordinated investigational drug services.
    Young LM; Haakenson CM; Weber JH; Tosch TJ
    Am J Hosp Pharm; 1984 Sep; 41(9):1792-6. PubMed ID: 6496514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy-based investigational drug services: a national survey.
    Rockwell K
    Top Hosp Pharm Manage; 1993 Apr; 13(1):1-15. PubMed ID: 10128788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of pharmacy-coordinated investigational drug services.
    Cipywnyk DM; McBride J
    Can J Hosp Pharm; 1991 Aug; 44(4):183-8, 200. PubMed ID: 10112895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and savings of investigational drug services.
    McDonagh MS; Miller SA; Naden E
    Am J Health Syst Pharm; 2000 Jan; 57(1):40-3. PubMed ID: 10630555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing oncology research protocols.
    Lunik MC
    Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving investigational drug service operations through development of an innovative computer system.
    Sweet BV; Tamer HR; Siden R; McCreadie SR; McGregory ME; Benner T; Tankanow RM
    Am J Health Syst Pharm; 2008 May; 65(10):969-73. PubMed ID: 18463347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical research: national survey of U.S. pharmacy-based investigational drug services--1997.
    Rockwell K; Bockheim-McGee C; Jones E; Kwon IW
    Am J Health Syst Pharm; 1999 Feb; 56(4):337-44. PubMed ID: 10690217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-evaluation model for clinical trials in a hospital pharmacy service.
    Idoate A; Ortega A; Carrera FJ; Aldaz A; Giráldez J
    Pharm World Sci; 1995 Sep; 17(5):172-6. PubMed ID: 8574214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a personal computer to support an investigational drug service.
    Abel JF; Moore RA; Foster TJ
    Hosp Pharm; 1990 Feb; 25(2):127-33. PubMed ID: 10103700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marketing an investigational drug service.
    Johnson VB; Crane V; Hayman JN
    Top Hosp Pharm Manage; 1993 Apr; 13(1):16-28. PubMed ID: 10128789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A perspective on investigational drug management.
    Hill DP; Browning DA
    Top Hosp Pharm Manage; 1993 Apr; 13(1):29-36. PubMed ID: 10128790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and financial analysis of an operating room satellite pharmacy.
    Stroup JW; Iglar AM
    Am J Hosp Pharm; 1992 Sep; 49(9):2198-202. PubMed ID: 1524061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational drug protocols--hidden costs.
    Mehl B
    Hosp Pharm; 1991 May; 26(5):459-61. PubMed ID: 10110663
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality assurance program for a hospital investigational-drug service.
    Tankanow RM; Savitsky ME; Volger BW; Ryan ML; Colvin CL
    Am J Hosp Pharm; 1989 May; 46(5):962-9. PubMed ID: 2729303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacist as an active member of the institutional review board.
    Mutnick AH; Miller LS
    Top Hosp Pharm Manage; 1993 Apr; 13(1):55-7. PubMed ID: 10128793
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigational drug information through a hospitalwide computer system.
    Iteen SA; Ceppaglia J
    Am J Hosp Pharm; 1992 Nov; 49(11):2746-8. PubMed ID: 1471640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.